tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IFRX Stock Latest News

InflaRx Concludes $30 Million Public Offering
Company AnnouncementsInflaRx Concludes $30 Million Public Offering
3d ago
6K
IFRX
InflaRx 8.25M share Spot Secondary priced at $2.00
PremiumThe Fly
InflaRx 8.25M share Spot Secondary priced at $2.00
7d ago
IFRX
InflaRx announces ordinary shares and warrants offering, no amount given
PremiumThe Fly
InflaRx announces ordinary shares and warrants offering, no amount given
8d ago
IFRX
InflaRx Secures EU Approval for GOHIBIC in Treating COVID-19-Induced ARDS
PremiumCompany Announcements
InflaRx Secures EU Approval for GOHIBIC in Treating COVID-19-Induced ARDS
1M ago
6K
IFRX
InflaRx announces EC grants marketing authorization to Gohibic for ARDS
PremiumThe Fly
InflaRx announces EC grants marketing authorization to Gohibic for ARDS
1M ago
IFRX
InflaRx Begins Phase 2a Trial for Innovative Anti-Inflammatory Drug
PremiumCompany AnnouncementsInflaRx Begins Phase 2a Trial for Innovative Anti-Inflammatory Drug
2M ago
6K
IFRX
InflaRx announces first patient dosed in 2a study of CSU, HS
Premium
The Fly
InflaRx announces first patient dosed in 2a study of CSU, HS
2M ago
IFRX
InflaRx initiated with a Buy at Lucid Capital
Premium
The Fly
InflaRx initiated with a Buy at Lucid Capital
3M ago
IFRX
InflaRx Gets EMA Nod for COVID-19 Treatment
PremiumCompany Announcements
InflaRx Gets EMA Nod for COVID-19 Treatment
3M ago
6K
IFRX
InflaRx receives positive CHMP opinion for GOHIBIC for SARS-CoV-2-induced ARDS
PremiumThe Fly
InflaRx receives positive CHMP opinion for GOHIBIC for SARS-CoV-2-induced ARDS
3M ago
IFRX
InflaRx Reports Q3 2024 Financial Results and Progress
PremiumCompany Announcements
InflaRx Reports Q3 2024 Financial Results and Progress
3M ago
IFRX
InflaRx Reports Rising Revenue Amidst Significant Losses
PremiumCompany Announcements
InflaRx Reports Rising Revenue Amidst Significant Losses
4M ago
6K
IFRX
InflaRx reports Q3 EPS (EUR 0.30) vs. (EUR 0.13) last year
PremiumThe FlyInflaRx reports Q3 EPS (EUR 0.30) vs. (EUR 0.13) last year
4M ago
IFRX
InflaRx expects cash to fund operations into 2026
Premium
The Fly
InflaRx expects cash to fund operations into 2026
4M ago
IFRX
Is IFRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is IFRX a Buy, Before Earnings?
4M ago
IFRX
InflaRx presents e-poster presentation of post hoc analysis of SHINE study
PremiumThe Fly
InflaRx presents e-poster presentation of post hoc analysis of SHINE study
5M ago
IFRX
InflaRx presents new preclinical findings for INF904
PremiumThe Fly
InflaRx presents new preclinical findings for INF904
6M ago
IFRX
InflaRx N.V. Reports Mid-Year Financial Results
PremiumCompany Announcements
InflaRx N.V. Reports Mid-Year Financial Results
7M ago
6K
IFRX
InflaRx reports Q2 EPS (24c), consensus (22c)
PremiumThe Fly
InflaRx reports Q2 EPS (24c), consensus (22c)
7M ago
IFRX
InflaRx Announces $75M Share Sales Agreement
PremiumCompany AnnouncementsInflaRx Announces $75M Share Sales Agreement
8M ago
6K
IFRX
InflaRx’s Drug Enters BARDA Phase 2 ARDS Trial
Premium
Company Announcements
InflaRx’s Drug Enters BARDA Phase 2 ARDS Trial
8M ago
6K
IFRX
Barda selects InflaRx’s GOHIBIC for clinical trial to evaluate ARDS therapeutic
Premium
The Fly
Barda selects InflaRx’s GOHIBIC for clinical trial to evaluate ARDS therapeutic
8M ago
IFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >